Development of surface engineered antigenic exosomes as vaccines for respiratory syncytial virus
Abstract Respiratory syncytial virus (RSV) is one of the main pathogens associated with lower respiratory tract infections in infants and young children worldwide. Exosomes secreted by antigen presenting cells (APCs) can elicit immune responses by carrying major histocompatibility complex (MHC) clas...
Guardado en:
Autores principales: | Suyeon Hong, Shaobo Ruan, Zachary Greenberg, Mei He, Jodi L. McGill |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/84ecf41bbf6f4edc8615a68cd553ed8f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
An epitope-specific chemically defined nanoparticle vaccine for respiratory syncytial virus
por: Armando Zuniga, et al.
Publicado: (2021) -
Engineered mRNA-expressed antibodies prevent respiratory syncytial virus infection
por: Pooja Munnilal Tiwari, et al.
Publicado: (2018) -
Author Correction: An epitope-specific chemically defined nanoparticle vaccine for respiratory syncytial virus
por: Armando Zuniga, et al.
Publicado: (2021) -
Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model
por: Jorge C. G. Blanco, et al.
Publicado: (2018) -
Meteorological drivers of respiratory syncytial virus infections in Singapore
por: Sheikh Taslim Ali, et al.
Publicado: (2020)